Downloads
XTitle | File |
---|---|
Insurance Claims Form | Claims form.pdf |
Account Application Form | JBB Application Form.pdf |
Support
XRizatriptan aurobindo rizatriptan 10 mg tablet
Other minor metabolites, the N-oxide, the 6-hydroxy compound, and the sulfate conjugate of the 6-hydroxy metabolite are not active at the 5-HT1B/1D receptor.Elimination The total radioactivity of the administered dose recovered over 120 hours in urine and feces was 82% and 12%, respectively, following a single 10 mg oral administration of 14C-rizatriptan. Food has no significant effect on the bioavailability of rizatriptan but delays the time to reach peak concentration by an hour. Discontinue rizatriptan benzoate if a cerebrovascular event occurs.As with other acute migraine therapies, before treating headaches in patients not previously diagnosed as migraineurs, and in migraineurs who present with atypical symptoms, care should be taken to exclude other potentially serious neurological conditions. Tabletten Candecor comp. 8 mg/12,5 mg Tabletten Capecitabin medac 150 mg Filmtabletten - OP60 3 AOK XIII (01.10.2014 - 30.09.2016) Bieter/Bietergemeinschaftsmitglied, der/das das Arzneimittel in eigenem Namen in Verkehr bringt medac Gesellschaft für klinische Spezialpräparate mbH neuraxpharm Arzneimittel GmbH neuraxpharm Arzneimittel GmbH neuraxpharm Arzneimittel GmbH neuraxpharm Arzneimittel GmbH neuraxpharm Arzneimittel GmbH neuraxpharm Arzneimittel GmbH neuraxpharm Arzneimittel GmbH neuraxpharm Arzneimittel GmbH neuraxpharm Arzneimittel GmbH Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Winthrop Arzneimittel GmbH Winthrop Arzneimittel GmbH 1 A Pharma GmbH 1 A Pharma GmbH 1 A Pharma GmbH ratiopharm GmbH ratiopharm GmbH ratiopharm GmbH ratiopharm GmbH ratiopharm GmbH ratiopharm GmbH ratiopharm GmbH ratiopharm GmbH Winthrop Arzneimittel GmbH Winthrop Arzneimittel GmbH Winthrop Arzneimittel GmbH Wirkstoff/ Wirkstoffkombination Capecitabin Chlorprothixen Chlorprothixen Chlorprothixen Chlorprothixen Chlorprothixen Chlorprothixen Chlorprothixen Chlorprothixen Chlorprothixen Ciclopirox Ciclopirox Ciclopirox Ciclopirox Ciclopirox Clodronsäure Clodronsäure Clodronsäure Clonidin Clonidin Clonidin Clonidin Clonidin Clonidin Clonidin Clonidin Clopidogrel Clopidogrel Clopidogrel PZN Arzneimittelbezeichnung(en) gem. Medication overuse headache may present as migraine-like daily headaches, or as a marked increase in frequency of migraine attacks. Approximately 14% of an oral dose is excreted in urine as unchanged rizatriptan while 51% is excreted as indole acetic acid metabolite, indicating substantial first pass metabolism.The plasma half-life of rizatriptan in males and females averages 2 to 3 hours.Cytochrome P450 IsoformsRizatriptan is not an inhibitor of the activities of human liver cytochrome P450 isoforms 3A4/5, 1A2, 2C9, 2C19, or 2E1; rizatriptan is a competitive inhibitor (Ki=1400 nM) of cytochrome P450 2D6, rosenhügel but only at high, clinically irrelevant concentrations.Special PopulationsGeriatric: Rizatriptan pharmacokinetics in healthy elderly non-migraineur volunteers (age 65 to 77 years) were similar to those in younger non-migraineur volunteers (age 18 to 45 years).Pediatric: The pharmacokinetics of rizatriptan was determined in pediatric migraineurs 6 to 17 years of age. Infrequent were tachycardia, cold extremities, and bradycardia.Digestive: Frequent were diarrhea and vomiting. Generica KG Wirkstoff/ Wirkstoffkombination Fluvastatin Fluvastatin Galantamin Galantamin Galantamin Galantamin Galantamin Galantamin Galantamin Galantamin Galantamin Gentamicin Gentamicin Gentamicin Glyceroltrinitrat Glyceroltrinitrat Ipratropium bromid Ipratropium bromid Ipratropium bromid Ipratropium bromid Irbesartan+Hydrochlorothiazid Irbesartan+Hydrochlorothiazid Irbesartan+Hydrochlorothiazid Irbesartan+Hydrochlorothiazid Irbesartan+Hydrochlorothiazid Irbesartan+Hydrochlorothiazid Irbesartan+Hydrochlorothiazid Irbesartan+Hydrochlorothiazid Irbesartan+Hydrochlorothiazid PZN 06714344 06714350 09632859 06195016 09632871 09632888 06195401 09632902 09632842 10408908 09901590 03942435 03928174 03928180 00827981 10182835 02200996 02201056 00539897 00539928 09505285 09505291 09505316 09505322 09505339 09505345 09505351 09505368 09505374 Arzneimittelbezeichnung(en) gem. KG GlaxoSmithKline GmbH & Co. Because their vasospastic effects may be additive, co-administration of rizatriptan benzoate and other 5-HT1 agonists within 24 hours of each other is contraindicated [see Contraindications (4)]. Infrequent was pharyngeal edema.Special Senses: Infrequent were blurred vision and tinnitus. Dosing in pediatric patients is based on the patient's body weight. The generic name of Rizatriptan Benzoate is rizatriptan benzoate. The no-effect dose for all of these effects was 5 mg/kg/day, associated with a maternal plasma exposure (AUC) approximately 7.5 times that in humans receiving the MRDD. It is not known whether this drug is excreted in human milk. Patients shown to have CAD and those with Prinzmetal’s variant angina should not receive 5-HT1 agonists. R. Pfleger Chemische Fabrik GmbH TAD Pharma GmbH TAD Pharma GmbH TAD Pharma GmbH TAD Pharma GmbH TAD Pharma GmbH TAD Pharma GmbH Wirkstoff/ Wirkstoffkombination Tilidin+Naloxon Tilidin+Naloxon Tilidin+Naloxon Tilidin+Naloxon Tilidin+Naloxon Tilidin+Naloxon Tilidin+Naloxon Tilidin+Naloxon Tilidin+Naloxon Tilidin+Naloxon Tilidin+Naloxon Tilidin+Naloxon Tilidin+Naloxon Tilidin+Naloxon Tilidin+Naloxon Timolol+Latanoprost Timolol+Latanoprost Timolol+Latanoprost Triamteren+Hydrochlorothiazid Triamteren+Hydrochlorothiazid Triamteren+Hydrochlorothiazid Valsartan Valsartan Valsartan Valsartan Valsartan Valsartan PZN Arzneimittelbezeichnung(en) gem.
Mirtazapin aurobindo
Adverse reactions for 3 of these patients included abdominal discomfort, fatigue, and dyspnea.In addition, based on the pharmacology of rizatriptan benzoate, hypertension or myocardial ischemia could occur after overdosage. Zulassung VALSACOR 40 mg Filmtabletten VALSACOR 80 mg Filmtabletten VALSACOR 80 mg Filmtabletten VALSACOR 80 mg Filmtabletten Valsacor comp. STADA 50 mg/4 mg Retardtabletten TILIDIN comp. Generica KG Aurobindo Pharma GmbH Aurobindo Pharma GmbH Pfizer Pharma GmbH Pfizer Pharma GmbH Pfizer Pharma GmbH Heumann Pharma GmbH & Co. Zulassung Tilidin comp. STADA 50 mg/4 mg pro 0,72 ml Tropfen zum Einnehmen, Lösung Tilidin comp. Rizatriptan binds with high affinity to human cloned 5-HT1B/1D receptors. This reflects the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.Geriatric patients who have other cardiovascular risk factors (e.g., diabetes, hypertension, geländer treppe smoking, obesity, strong family history of coronary artery disease) should have a cardiovascular evaluation prior to receiving rizatriptan benzoate [see Warnings and Precautions (5.1)]. Generica KG neuraxpharm Arzneimittel GmbH neuraxpharm Arzneimittel GmbH neuraxpharm Arzneimittel GmbH neuraxpharm Arzneimittel GmbH Wirkstoff/ Wirkstoffkombination Salmeterol+Fluticason Salmeterol+Fluticason Salmeterol+Fluticason Salmeterol+Fluticason Salmeterol+Fluticason Salmeterol+Fluticason Salmeterol+Fluticason Salmeterol+Fluticason Salmeterol+Fluticason Salmeterol+Fluticason Salmeterol+Fluticason Salmeterol+Fluticason Salmeterol+Fluticason Salmeterol+Fluticason Salmeterol+Fluticason Sulfasalazin Sulfasalazin Telmisartan Telmisartan Telmisartan Telmisartan Telmisartan Telmisartan Telmisartan Ticlopidin Ticlopidin Ticlopidin Ticlopidin PZN 00427827 03180787 00427833 03180793 00427862 03180818 01474237 01474243 01474220 01288405 03180853 01288434 03180824 01288457 03180830 04947742 04947759 10541607 04769944 04770410 04770456 04770580 04771438 04771817 05395150 01267283 01267308 01267314 Arzneimittelbezeichnung(en) gem. Gastrointestinal decontamination, (i.e., gastric lavage followed by activated charcoal) should be considered in patients suspected of an overdose with rizatriptan benzoate. Nervous system disorders: Infrequent were coordination abnormal, disturbance in attention, and presyncope. Zulassung Clozapin-neuraxpharm 100mg Clozapin-neuraxpharm 100mg Clozapin-neuraxpharm 100mg Clozapin-neuraxpharm 200 mg Clozapin-neuraxpharm 200 mg Clozapin-neuraxpharm 200 mg Clozapin-neuraxpharm 25mg Clozapin-neuraxpharm 25mg Clozapin-neuraxpharm 25mg Clozapin-neuraxpharm 50mg Clozapin-neuraxpharm 50mg Clozapin-neuraxpharm 50mg Famina-ratiopharm 20 Famina-ratiopharm 20 Famina-ratiopharm 20 Famina-ratiopharm 30 Famina-ratiopharm 30 DONEPEZIL-HCL BASICS 5 mg Filmtabletten DONEPEZIL-HCL BASICS 5 mg Filmtabletten DONEPEZIL-HCL BASICS 5 mg Filmtabletten DONEPEZIL-HCL BASICS 10 mg Filmtabletten DONEPEZIL-HCL BASICS 10 mg Filmtabletten DONEPEZIL-HCL BASICS 10 mg Filmtabletten DONEPEZIL-HCL BASICS 5 mg Schmelztabletten DONEPEZIL-HCL BASICS 5 mg Schmelztabletten DONEPEZIL-HCL BASICS 5 mg Schmelztabletten DONEPEZIL-HCL BASICS 10 mg Schmelztabletten DONEPEZIL-HCL BASICS 10 mg Schmelztabletten DONEPEZIL-HCL BASICS 10 mg Schmelztabletten 5 AOK XIII (01.10.2014 - 30.09.2016) Bieter/Bietergemeinschaftsmitglied, der/das das Arzneimittel in eigenem Namen in Verkehr bringt Hexal AG Hexal AG Hexal AG Hexal AG Hexal AG Hexal AG Hexal AG Hexal AG Hexal AG Hexal AG Hexal AG Hexal AG Hexal AG cell pharm Gesellschaft für pharmazeutische und diagnostische Präparate mbH cell pharm Gesellschaft für pharmazeutische und diagnostische Präparate mbH Pfizer Pharma GmbH Pfizer Pharma GmbH neuraxpharm Arzneimittel GmbH neuraxpharm Arzneimittel GmbH neuraxpharm Arzneimittel GmbH neuraxpharm Arzneimittel GmbH neuraxpharm Arzneimittel GmbH neuraxpharm Arzneimittel GmbH neuraxpharm Arzneimittel GmbH neuraxpharm Arzneimittel GmbH neuraxpharm Arzneimittel GmbH AbZ-Pharma GmbH AbZ-Pharma GmbH Wirkstoff/ Wirkstoffkombination Estradiol Estradiol Estradiol Estradiol Estradiol Estradiol Estradiol Estradiol Estradiol Estradiol Estradiol Estradiol Estradiol Estramustin Estramustin Exemestan Exemestan Fluphenazin Fluphenazin Fluphenazin Fluphenazin Fluphenazin Fluphenazin Fluphenazin Fluphenazin Fluphenazin Fluvastatin Fluvastatin PZN 09120906 09121053 08416355 08416378 06956975 06956998 08416384 08416409 00620116 02587162 01220666 08416438 00620139 06983096 06983110 08819136 08819142 04935584 04935590 01852277 08515471 08515488 04935621 04935638 08515459 08515465 06714315 06714321 Arzneimittelbezeichnung(en) gem. In patients who experience symptoms or signs suggestive of non-coronary vasospasm reaction following the use of any 5-HT1 agonist, the suspected vasospasm reaction should be ruled out before receiving additional rizatriptan benzoate doses.Reports of transient and permanent blindness and significant partial vision loss have been reported with the use of 5-HT1 agonists.
Sertralin aurobindo alkohol
Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc. N-monodesmethyl-rizatriptan, a metabolite with activity similar to that of parent compound at the 5-HT1B/1D receptor, daylong gel is formed to a minor degree. The following section enumerates potentially important adverse events that have occurred in clinical practice and which have been reported spontaneously to various surveillance systems. STADA 50 mg/4 mg pro 0,72 ml Tropfen zum Einnehmen, Lösung Tilidin comp. The product has been approved out of Unit VII (SEZ) formulations facility in Hyderabad. Event frequencies are calculated as the number of pediatric patients 6 to 17 years of age who used rizatriptan benzoate orally disintegrating tablets and reported an event divided by the total number of patients exposed to rizatriptan benzoate orally disintegrating tablets (N=1068). The blister pack should then be peeled open with dry hands and the orally disintegrating tablet placed on the tongue, sildenafil 1a pharma 50 mg where it will dissolve and be swallowed with the saliva. The presence of a migraine headache did not appear to affect the absorption or pharmacokinetics of rizatriptan. Events are further classified within body system categories and enumerated in order of decreasing frequency using the following definitions: frequent adverse events are those defined as those occurring in at least (>)1/100 patients; infrequent adverse experiences are those occurring in 1/100 to 1/1000 patients; and rare adverse experiences are those occurring in fewer than 1/1000 patients.General: Infrequent was facial edema. KG ratiopharm GmbH ratiopharm GmbH ratiopharm GmbH ratiopharm GmbH ratiopharm GmbH 1 A Pharma GmbH Wirkstoff/ Wirkstoffkombination Levomepromazin Levomepromazin Levomepromazin Levomepromazin Levomepromazin Levomepromazin Levonorgestrel+Ethinylestradiol Levonorgestrel+Ethinylestradiol Levonorgestrel+Ethinylestradiol Levonorgestrel+Ethinylestradiol Levonorgestrel+Ethinylestradiol Levonorgestrel+Ethinylestradiol Levonorgestrel+Ethinylestradiol Levonorgestrel+Ethinylestradiol Levonorgestrel+Ethinylestradiol Levonorgestrel+Ethinylestradiol Levonorgestrel+Ethinylestradiol Levonorgestrel+Ethinylestradiol Levonorgestrel+Ethinylestradiol Levonorgestrel+Ethinylestradiol Levonorgestrel+Ethinylestradiol Levonorgestrel+Ethinylestradiol Levonorgestrel+Ethinylestradiol Lovastatin Lovastatin Lovastatin Lovastatin Lovastatin Metformin PZN 07229237 07229243 07229266 07464056 06867473 06867496 04027906 04088753 02711001 04922630 04923457 04923486 04018072 04922363 04922475 04922305 05700765 01550955 01550961 01550978 04923664 04923687 04923693 00187240 00187398 00187406 00187702 00187719 00113767 Arzneimittelbezeichnung(en) gem. Rizatriptan benzoate should not be administered to patients with a history of stroke or transient ischemic attack [see Contraindications (4)]. The adverse reaction pattern in pediatric patients is expected to be similar to that in adults.
Sertralin aurobindo 50 mg
Zulassung Candesartan Heumann 32 mg Tabletten Candesartan Heumann 8 mg Tabletten Candesartan Heumann 8 mg Tabletten Candesartan Heumann 8 mg Tabletten CANDECOR 16 mg Tabletten CANDECOR 16 mg Tabletten CANDECOR 16 mg Tabletten CANDECOR 4 mg Tabletten CANDECOR 4 mg Tabletten CANDECOR 4 mg Tabletten CANDECOR 32 mg Tabletten CANDECOR 32 mg Tabletten CANDECOR 32 mg Tabletten CANDECOR 8 mg Tabletten CANDECOR 8 mg Tabletten CANDECOR 8 mg Tabletten Candecor comp. Some of these reactions occurred in patients without known coronary artery disease (CAD). Life-threatening disturbances of cardiac rhythm, including ventricular tachycardia and ventricular fibrillation leading to death, gele pinigu medis have been reported within a few hours following the administration of 5-HT1 agonists. Filmtabletten Valsacor comp. 160 mg/25 mg Filmtabletten Valsacor comp. Teratogenic EffectsPregnancy Category CThere are no adequate and well-controlled studies in pregnant women. The mean oral absolute bioavailability of the rizatriptan benzoate tablet is about 45%, and mean peak plasma concentrations (Cmax) are reached in approximately 1 to 1.5 hours (Tmax). The product's dosage form is tablet, orally disintegrating and is administered via oral form. As with other 5-HT1 agonists, sensations of tightness, pain, pressure, and heaviness in the precordium, throat, neck and jaw commonly occur after treatment with rizatriptan benzoate and are usually non-cardiac in origin. Because many drugs are excreted in human milk, caution should be exercised when rizatriptan benzoate is administered to a nursing woman. All effects on the offspring in both studies occurred in the absence of any apparent maternal toxicity.In embryofetal development studies, no teratogenic effects were observed when pregnant rats and rabbits were administered doses of 100 and 50 mg/kg/day, super kamagra per nachnahme respectively, during organogenesis. Filmtabletten Valsacor comp. 320 mg/12,5 mg Filmtabletten Valsacor comp. Zulassung Metoprolol ZOT STADA 200 mg Retardtabletten Metoprololsuccinat STADA 23,75 mg Retardtabletten Metoprololsuccinat STADA 23,75 mg Retardtabletten Metoprololsuccinat STADA 23,75 mg Retardtabletten Metoprololsuccinat STADA 47,5 mg Retardtabletten Metoprololsuccinat STADA 47,5 mg Retardtabletten Metoprololsuccinat STADA 47,5 mg Retardtabletten Metoprololsuccinat STADA 95 mg Retardtabletten Metoprololsuccinat STADA 95 mg Retardtabletten Metoprololsuccinat STADA 95 mg Retardtabletten Metoprololsuccinat STADA 190 mg Retardtabletten Metoprololsuccinat STADA 190 mg Retardtabletten Metoprololsuccinat STADA 190 mg Retardtabletten Naproxen AL 250 Naproxen AL 250 Naproxen AL 250 Naproxen AL 500 Naproxen AL 500 Naproxen AL 500 Nebivolol Glenmark 5 mg Tabletten Nebivolol Glenmark 5 mg Tabletten Nebivolol Glenmark 5 mg Tabletten Viramune 100 Retardtabletten Viramune 400 mg Retardtabletten Viramune 400 mg Retardtabletten VIRAMUNE 50mg/5ml Suspension zum Einnehmen VIRAMUNE 200 mg Tabletten VIRAMUNE 200 mg Tabletten VIRAMUNE 200 mg Tabletten 13 AOK XIII (01.10.2014 - 30.09.2016) Bieter/Bietergemeinschaftsmitglied, der/das das Arzneimittel in eigenem Namen in Verkehr bringt Heunet Pharma GmbH Heunet Pharma GmbH Heunet Pharma GmbH Heunet Pharma GmbH Heunet Pharma GmbH Heunet Pharma GmbH Heunet Pharma GmbH Heunet Pharma GmbH Heunet Pharma GmbH Heunet Pharma GmbH Heunet Pharma GmbH Heunet Pharma GmbH Heunet Pharma GmbH Heunet Pharma GmbH Heunet Pharma GmbH Heunet Pharma GmbH Heunet Pharma GmbH Heunet Pharma GmbH VELVIAN Germany GmbH VELVIAN Germany GmbH VELVIAN Germany GmbH VELVIAN Germany GmbH Hexal AG Hexal AG Aurobindo Pharma GmbH Aurobindo Pharma GmbH Aurobindo Pharma GmbH Aurobindo Pharma GmbH Aurobindo Pharma GmbH Wirkstoff/ Wirkstoffkombination Olanzapin Olanzapin Olanzapin Olanzapin Olanzapin Olanzapin Olanzapin Olanzapin Olanzapin Olanzapin Olanzapin Olanzapin Olanzapin Olanzapin Olanzapin Olanzapin Olanzapin Olanzapin Progesteron Progesteron Progesteron Progesteron Promethazin Promethazin Quetiapin Quetiapin Quetiapin Quetiapin Quetiapin PZN 09100134 09100140 09100157 09100163 09100186 09100192 09100045 09100051 09100068 09100200 09100217 09100223 09100074 09100080 09100097 09100105 09100111 09100128 09915161 09915184 09915209 09915215 08668341 08668358 01339491 01339516 01339522 01340005 01340407 Arzneimittelbezeichnung(en) gem.
Rizatriptan
Rizatriptan is extensively excreted in rat milk, with levels in milk at least 5-fold higher than levels in maternal plasma. Rizatriptan benzoate is contraindicated in patients with uncontrolled hypertension [see Contraindications (4)]. Other Events Observed in Association with the Administration of rizatriptan benzoate orally disintegrating tablets in Pediatric PatientsIn the following section, the frequencies of less commonly reported adverse events are presented. The efficacy and safety of treatment with more than one dose of rizatriptan benzoate orally disintegrating tablets within 24 hours in pediatric patients 6 to 17 years of age have not been established. The maximum daily dose should not exceed 30 mg in any 24-hour period. Also, patients with migraine may be at increased risk of certain cerebrovascular events (e.g., stroke, hemorrhage, transient ischemic attack). AbsorptionRizatriptan is completely absorbed following oral administration. Ergot-containing drugs have been reported to cause prolonged vasospastic reactions. Zulassung 11 AOK XIII (01.10.2014 - 30.09.2016) Bieter/Bietergemeinschaftsmitglied, der/das das Arzneimittel in eigenem Namen in Verkehr bringt Hexal AG Hexal AG Hexal AG Hexal AG Hexal AG Hexal AG Hexal AG Hexal AG Hexal AG Hexal AG Hexal AG Hexal AG Hexal AG Hexal AG Hexal AG Hexal AG Hexal AG STADApharm GmbH STADApharm GmbH STADApharm GmbH STADApharm GmbH STADApharm GmbH STADApharm GmbH STADApharm GmbH STADApharm GmbH STADApharm GmbH STADApharm GmbH STADApharm GmbH STADApharm GmbH Wirkstoff/ Wirkstoffkombination Metoprolol Metoprolol Metoprolol Metoprolol Metoprolol Metoprolol Metoprolol Metoprolol Metoprolol Metoprolol Metoprolol Metoprolol Metoprolol Metoprolol Metoprolol Metoprolol Metoprolol Metoprolol Metoprolol Metoprolol Metoprolol Metoprolol Metoprolol Metoprolol Metoprolol Metoprolol Metoprolol Metoprolol Metoprolol PZN 00850537 00850543 06183059 03913072 03913089 00850394 00850402 00850419 00850425 00850431 00850448 00850454 00850460 00850477 00539331 00539348 00539354 03722538 03722544 03722567 03722573 01663197 01663205 01663228 01663240 01663263 01663286 01663317 01663292 Arzneimittelbezeichnung(en) gem.